Cardiac Disease
273
33
44
146
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Published Results
25 trials with published results (9%)
Research Maturity
146 completed trials (53% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
6.2%
17 terminated out of 273 trials
89.6%
+3.0% vs benchmark
7%
19 trials in Phase 3/4
17%
25 of 146 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 146 completed trials
Clinical Trials (273)
Rectus Sheath Block in Cardiac Surgery
BoStOn SCientific Rhythm MAnagemenT REgiStry (SOCRATES)
ARTEMIS: Ravulizumab to Protect Patients With CKD From CSA-AKI and MAKE
Evaluation of a Remote Behavioural Stress Recovery Intervention for Myocardial Infarction Patients Younger Than Fifty-five (BRIM-55): A Feasibility Study
Well-being Program for Caregivers of Patients With Advanced Cardiac and Pulmonary Disease
Predicting Cerebrovascular Adverse Events Post Cardiac Surgery
Dynamic Cardio-vascular, Cerebro-vascular and Cortical Interaction in Healthy Adult Subjects
HeartGuide: Preliminary Study
Impact of Mindfulness-Based Stress Reduction Meditation Practice on Patients After Cardiac Rehabilitation.
Assessment of Patients Undergoing Cardiac Surgery and Admitted to the Intensive Care Unit
A Study of Electrocardiogram and Focused Cardiac Ultrasound for Enhanced Cardiac Disease Screening
Unrecognised Comorbidity Detection in Hospitalised Patients
Left Bundle Branch Area Pacing (LBBAP) PMCF Study
Digital diagnoSis of Cardiac sOUNd in peDiatric Patients [DI-SOUND Study]
Efferon LPS Hemoadsorption in Cardiac Surgery Patients
Low Tidal MEChanical Ventilation Against NO Ventilation During Cardiopulmonary Bypass Heart Surgery
Connected Electronic Wrist Strap for Patient Follow-up After Cardiac Surgery
Multivariate Approach to the Numerical Assessment of Cortical - Autonomic - VAscular Dynamic Interplay
Cardiac Clearance vs G60 Hip Frailty Index
Factor VIII Inhibitor Bypass Activity (FEIBA) Versus Fresh Frozen Plasma As First Line Therapy For Bleeding After Cardiac Surgery